Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMSRAMRCGP

Prevention and NHS screening programmes

Essential points for quick revision.

Saved on this device

Synopsis

Deliver prevention systematically, distinguish screening from diagnostic care, explain benefits and harms, and apply current England programme eligibility without missing symptomatic disease.

  • Prevention includes upstream action on living conditions, primary prevention before disease, secondary prevention through early detection, and tertiary prevention that reduces disability or recurrence.
  • Screening proactively offers a standard pathway to an apparently well defined population; symptoms require diagnostic assessment even when the person is outside screening age or recently had a negative screen.
  • In England, cervical screening is offered from age 25 to 64 every five years, with earlier recall when HPV or cell-change pathways require it.

Reasoning priorities

01
Eligibility and anatomy check

Confirm that the correct programme and invitation route apply.

Use age, nation, registration, organ inventory, previous results and high-risk pathways rather than demographic assumptions alone.

Worked reasoning

Worked case: rectal bleeding after a negative FIT kitMove from screening to diagnosis

A 57-year-old returned a negative routine bowel screening FIT six months ago and now reports persistent rectal bleeding with change in bowel habit.

  1. Clarify duration, bleeding, bowel change, weight, anaemia symptoms, abdominal findings, medicines and family history; assess immediate instability and relevant examination needs.
  2. Reason that the previous test was performed in an asymptomatic screening pathway and cannot exclude the cause of new symptoms; apply the current symptomatic colorectal assessment guidance.
  3. The final action is diagnostic evaluation and referral based on the clinical pathway, not reassurance or waiting for the next two-yearly screening kit.
  4. Verify ownership of investigations and referral, give explicit worsening advice for heavy bleeding, syncope or severe pain, and check that the patient understands the distinction between screening and diagnosis.
Cervical invitation checkUse age, cervix and prior pathway

A patient asks whether a routine invitation is due.

Open full textbook Answer 2 questions
Sources and review status8 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom